Name: Taysha Gene Therapies, Inc. (TSHA) Balance Sheet
Creator: FinSpry

Taysha Gene Therapies Balance Sheet Analysis

Assets, liabilities, and stockholders equity in millions USD

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for Taysha Gene Therapies, Inc. (TSHA) - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Current Assets
Cash and Cash Equivalents	139.04	143.90	87.88	149.10	251.25
Cash & Short-Term Investments	139.04	143.90	87.88	149.10	251.25
Accounts Receivable	0.00	0.00	0.00	0.00	0.00
Inventory	0.00	0.00	0.00	0.00	0.00
Other Current Assets	3.09	2.00	0.47	3.87	3.83
Total Current Assets	142.13	149.87	96.42	159.60	257.88
Non-Current Assets
Property, Plant & Equipment (Net)	15.87	20.41	25.91	50.61	0.29
Other Non-Current Assets	2.37	2.46	3.95	3.74	0.72
Total Non-Current Assets	18.23	22.86	29.86	54.35	1.00
Total Assets	160.36	172.73	126.28	213.96	258.88
Current Liabilities
Accounts Payable	3.59	18.65	29.23	21.76	1.99
Short-Term Debt	1.88	0.00	0.00	0.00	0.00
Accrued Liabilities	9.59	5.65	12.13	25.85	4.87
Deferred Revenue	9.77	18.11	33.56	0.00	0.00
Other Current Liabilities	10.99	3.42	2.52	4.14	0.26
Total Current Liabilities	26.23	36.76	62.79	51.75	7.13
Non-Current Liabilities
Long-Term Debt	61.30	59.46	58.41	37.19	0.00
Other Non-Current Liabilities	1.31	1.58	4.13	3.74	0.45
Total Non-Current Liabilities	62.61	61.04	62.54	66.83	0.45
Total Liabilities	88.84	97.79	125.33	118.57	7.58
Stockholders' Equity
Common Stock	0.00	0.00	0.00	0.00	0.00
Retained Earnings	-602.31	-513.00	-401.44	-235.65	-61.13
Accumulated Other Comprehensive Income	-4.03	0.00	0.00	0.00	0.00
Additional Paid-in Capital	677.86	587.94	402.39	331.03	312.43
Shares Outstanding	204.94	186.96	63.21	38.47	0.00
Total Stockholders' Equity	71.53	74.94	0.95	95.38	251.30
Total Liabilities & Equity	160.36	172.73	126.28	213.96	258.88